Showing results (771-780 of 9,059) with videos related to

Sort By:
Pageof 906
Rheumatology (Oxford, England)|April 1, 2014
Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitorsYou Jae Kim, Yong-Gil Kim, Tae Sun Shim, et al.
Rheumatology (Oxford, England)|March 10, 2021
Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort StudyEve M D Smith, Sajida Rasul, Coziana Ciurtin, et al.
Rheumatology (Oxford, England)|March 8, 2021
Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill countLinda Hartman, Maurizio Cutolo, Reinhard Bos, et al.
Rheumatology (Oxford, England)|March 11, 2021
Real-life analysis of the causes of death in patients consecutively followed for giant cell arteritis in a French centre of expertiseLuca Antonini, Anael Dumont, Amandine Lavergne, et al.
Rheumatology (Oxford, England)|March 11, 2021
Diagnosing axial spondyloarthritis: estimation of the disease probability in patients with a priori different likelihoods of the diagnosisDenis Poddubnyy, Fabian Proft, Laura Spiller, et al.
Rheumatology (Oxford, England)|July 23, 2019
Centre effects and case-mix in early rheumatoid arthritis observational cohorts: a narrative reviewMark Yates, Katie Bechman, Sam Norton, et al.
Rheumatology (Oxford, England)|March 11, 2021
Effects of fenofibrate therapy on renal function in primary gout patientsXinde Li, Wenyan Sun, Jie Lu, et al.
Rheumatology (Oxford, England)|November 1, 2018
Under crossfire: thromboembolic risk in systemic lupus erythematosusGiuseppe A Ramirez, Maria Efthymiou, David A Isenberg, et al.
Rheumatology (Oxford, England)|April 5, 2017
Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosusLaurie S Davis, Andreas M Reimold
Rheumatology (Oxford, England)|June 6, 2008
The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndromeR J Barry, N Sutcliffe, D A Isenberg, et al.
Pageof 906